Showing results (1451-1460 of 6,159) with videos related to
Sort By:
Pageof 616
Nature Medicine|July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trialSi-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.Nature Medicine|July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim resultsRaffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.Nature Medicine|July 10, 2023
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim resultsMartin Gutierrez, Wei-Sen Lam, Matthew D Hellmann, et al.Nature Medicine|July 5, 2023
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemiaNathaniel D Anderson, Jack Birch, Theo Accogli, et al.Nature Medicine|July 3, 2023
Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosisAnn-Kathrin Schalkamp, Kathryn J Peall, Neil A Harrison, et al.Nature Medicine|August 17, 2023
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trialAri VanderWalde, Shay L Bellasea, Kari L Kendra, et al.Nature Medicine|August 15, 2023
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial resultsAlexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, et al.Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M HoltzmanNature Medicine|August 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Jordan L Whatley, Frank Eder, et al.Nature Medicine|August 28, 2023
Cell-free DNA methylome analysis for early preeclampsia predictionMarie De Borre, Huiwen Che, Qian Yu, et al.Pageof 616